Shane Ward

This profile gathers the share dealings of Shane Ward across 2 companies, led by Cidara Therapeutics, Inc. and Aravive, Inc. The record holds 10 filings, for trades running from 28 January 2016 to 7 January 2026.

Sales make up the whole of the open-market record (3 sales, €52k). Outside the open market, there are 6 share grants.

Most recently, on 7 January 2026, the filings show a transaction worth €4.8M in Cidara Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.